THVD-102 Demonstrates Promising Potential as an Orally Administered Treatment for Hyperhidrosis

tegemeo
Posts: 8
Joined: Tue Jul 30, 2013 6:17 pm

THVD-102 Demonstrates Promising Potential as an Orally Administered Treatment for Hyperhidrosis

Postby tegemeo » Mon Oct 03, 2016 1:20 pm

THVD-102 is a combination drug product composed of a muscarinic antagonist (oxybutynin) and a muscarinic agonist (pilocarpine) in a twice daily, oral formulation for the treatment of primary focal hyperhidrosis. In multiple trials, oxybutynin has shown activity in hyperhidrosis but is rarely used due to poor patient tolerance, most commonly dry mouth. Pilocarpine counters the dry mouth caused by oxybutynin without interfering with the beneficial effect of oxybutynin when the two drugs are formulated together in a manner that is covered by the intellectual property of TheraVida, Inc.

http://www.businesswire.com/news/home/2 ... -Treatment



Return to “General Forum About Hyperhidrosis”

Who is online

Users browsing this forum: No registered users and 1 guest